Moderna Announces Clinical Update on Bi-Valent Covid-19 Booster Platform
investors.modernatx.com
investors.modernatx.com
In Canada, >80% of people received two doses of vaccine whereas only ~60% have received a booster dose. I expect an even sharper drop-off for any future bivalent vaccine, regardless of how effective it is.
On the positive side, these results will encourage companies to pursue a multivalent strategy earlier in the future. We need to get to a point where we can fully utilize the flexibility of mRNA vaccine platforms. Multivalent should be the default and vaccines should be updated as new strains emerge. Currently the regulatory process doesn't allow that.